Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

RegulatoryapprovedAffera™ Mapping and Ablation SystemSphere-9™ CatheterPositive

AI Analysis

Summary

Medtronic announced an expanded CE Mark indication for its Affera Mapping and Ablation System and Sphere-9 Catheter for treating ventricular arrhythmias, with Sphere-9 being the first dual energy catheter CE Marked for this application.

Outcome Details

CE Mark indication expansion for ventricular arrhythmia treatment

Importance:6/10

Sentiment:

0.70

CE Markregulatory approvalventricular arrhythmiasmapping and ablationcatheterEurope

Related Companies

$MDT

Read the original article

Published by PR Newswire Biotech on August 6, 2026 11:00 AM

Read Original